Tyra Biosciences Inc. Rings the Closing Bell in Celebration of its IPO
ABOUT THIS EVENT
Tyra Biosciences (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, visits the Nasdaq MarketSite in Times Square to ring the Closing Bell.